In partnership with
Things are finally starting to really heat up. With interest rates easing, investor confidence back, and a massive pipeline of companies ready to hit the public markets…
Now’s the time to take the 2026 IPO market seriously.
We’re talking dozens of deals already filed or in the works, with experts predicting anywhere from 200-230 IPOs this year, potentially raising $40-$60 billion dollars.
But it’s not just the mega unicorns stealing the spotlight anymore. And even though it is IPO liftoff season, we’re not talking about Space X today…
See, there’s a real mix of solid, smaller-cap established players and innovative ones jumping in, and the big Wall Street names are all over them.
Goldman Sachs, Morgan Stanley, J.P. Morgan, BofA Securities… these heavy hitters are leading the charge, along with others like Jefferies, Barclays, and more.
When those guys are involved, you know the deals have serious credibility.
REVEALED: Trump just green-lit what could be the biggest AI budget in history.
Over $1 trillion aimed at AI-powered defense, surveillance, and autonomous weapons.
But the real money isn't in fighter jets..
It's in the small AI company supplying the core tech — the same one rumored to be working with Elon Musk.
It's tiny compared to Nvidia…
Yet it could be the fastest way to ride Trump's AI surge + Musk's next supercycle.
Take this one retailer that’s about to debut, for example. It’s a go-to spot for affordable home furnishings, with hundreds of stores across the U.S. offering sofas, beds, dining sets, all that good stuff for folks who want quality without breaking the bank.
Sounds boring, yes. But they’ve been growing like crazy, backed by private equity, and now they’re eyeing a valuation around 2.5 billion dollars.
$2.5 billion for a furniture store!
The underwriters here? We’ve got Goldman Sachs, BofA Securities, and Evercore leading the bookrunners, with J.P. Morgan and Morgan Stanley popping up in some filings too.
Classic top-tier lineup.
Then there’s a biotech company pushing the envelope on cancer treatments, focusing on immuno-responsive therapies for tough-to-treat types.
They’re in late-stage clinical trials with some promising candidates, and the market’s buzzing because oncology is hot right now.
They’re looking to raise hundreds of millions, with a valuation pushing close to a billion.
Underwriters include J.P. Morgan, Morgan Stanley, and BofA Securities as the main players. Again, the elite crew that screams confidence to investors.
Over in the power sector, there’s this industrial player making electrical distribution gear, stuff that’s crucial for data centers, factories, and all the high-demand spots where AI and tech are exploding.
Demand for reliable power infrastructure is through the roof, and this company’s positioned perfectly to cash in.
They’re aiming for a massive raise, potentially over a billion and a half, with an eye-popping valuation in the eight-billion-plus range.
Leading the charge? Goldman Sachs, Jefferies, and Morgan Stanley, with J.P. Morgan and BofA in the mix too.
When you see that kind of firepower, it tells you the market’s hungry for these infrastructure plays.
On the biotech side again, we have a European outfit developing therapies for immune and inflammatory diseases, like treatments for conditions such as Crohn’s.
They’re in Phase two trials with solid early data, and it’s all about filling unmet needs in tough areas.
See every move your competitors make.
Get unlimited access to the world’s top-performing Facebook ads — and the data behind them. Gethookd gives you a library of 38+ million winning ads so you can reverse-engineer what’s working right now. Instantly see your competitors’ best creatives, hooks, and offers in one place.
Spend less time guessing and more time scaling.
Start your 14-day free trial and start creating ads that actually convert.
Targeting a raise around two hundred million, with a valuation up to eight hundred million or so.
Underwriters are J.P. Morgan, Morgan Stanley, Leerink Partners… top-notch specialists in life sciences.
Then we’ve got a mobile advertising tech firm, helping apps grow through smart user acquisition and performance marketing.
Backed by a big private equity giant, they’re riding the digital ad wave, especially with mobile gaming and apps booming.
They’re shooting for a huge debut, potentially over seven hundred million raised, and a valuation north of five billion.
Underwriters include Goldman Sachs, Morgan Stanley, Jefferies, Barclays. Another dream team.
And for something a bit more consumer-friendly, there’s this organic baby and kids’ food brand making fresh, nutritious purees and pouches. Think convenient, healthy options for parents who want the best for their kids, without the junk.
Co-founded by a celebrity, it’s all about clean ingredients and sustainability.
They’re planning a solid raise around $200 million, with a valuation in the $700 million range.
Goldman Sachs and J.P. Morgan are leading, with BofA Securities involved; perfect for a consumer staples play.
Look, these aren’t just random names; they’re diverse, from retail and power to biotech and tech, all with real growth stories. And the common thread?
Those powerhouse underwriters, Goldman, Morgan Stanley, J.P. Morgan, BofA, and the rest, are betting big.
It feels like the floodgates are opening in 2026, and if the momentum holds, we’re in for an exciting ride.
Investors are circling, roadshows are packed, and the market’s ready to welcome this fresh wave.
Buckle up… it’s gonna be a wild, prosperous year for IPOs.
One of my last IPO recommendations has already knitted about 32% and it's barely been a week. Things are rolling.
So, subscribe to IPO Stream Premium to get detailed alerts on the IPOs I believe offer YOU the biggest chances of success… by clicking HERE.
At just $9 a month, I think you’ll find the Premium service is more than worth it.
-Tim
